Bookmark and Share

Micro-Caps on the Move; Cannabis Science Inc. (CBIS), Santo Mining Corp. (SANP), Amarantus BioSciences Corp. (AMBS)

Shares of Cannabis Science Inc. (PINK: CBIS), a development stage company engaged in the business of developing pharmaceutical grade medical cannabis products, are soaring in trading today.

At last check, CBIS shares were trading 30.43% higher at $0.0900 on above average volume of 48.17 million. The stock hit an intra-day high of $0.10 today. CBIS has now gained more than 91% in the last three trading sessions.

CBIS shares are soaring after the company today provided corporate guidance on preclinical initiative and recent corporate developments for its shareholders. Dr. Robert Melamede, President and CEO of Cannabis Science, said that over the past 3 quarters, CBIS has successfully initiated a strong biomedical research program for the scientific investigation of its lead compound to demonstrate the anti-viral and anti-oncogenic properties based on multiple signaling pathways of cannabinoid therapeutics.

Shares of Santo Mining Corp. (OTC: SANP), a Dominican Republic-based junior mineral exploration and development company focusing on gold production opportunities, are rallying in trading today.

At last check, SANP shares were trading 16.13% higher at $1.08 on above average volume of 2.58 million. The stock hit an intra-day high of $1.08 in trading today. In the last three trading sessions, SANP shares have gained 34.37%.

SANP shares are soaring in trading today after the company said that it is mobilizing its exploration strike team for an intensive 90 days of exploration on its precious and base metal claims in the mineral rich Hispaniola Gold Copper Arc in central Dominican Republic.

Shares of Amarantus BioSciences Inc. (OTC: AMBS), a development-stage biotechnology company engaged in the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI), and other human diseases, are seeing a huge rally in trading today.

At last check, AMBS shares were trading 39.44% higher at $0.0502 on above average volume of 40.55 million.

AMBS shares are soaring in trading today after the company announced it outlined terms for NuroPro Parkinson’s blood test joint venture with Rainbow BioSciences, a biotech subsidiary of Rainbow Coral Corp.


Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

All stories in are for informational purposes only. This is NOT a stock recommendation. This story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at . About is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.